320 related articles for article (PubMed ID: 11213385)
1. [Renal osteodystrophy (3); its treatment in dialysis patients].
Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
3. CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
Melamed ML; Buttar RS; Coco M
Adv Chronic Kidney Dis; 2016 Jul; 23(4):262-9. PubMed ID: 27324680
[TBL] [Abstract][Full Text] [Related]
4. Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.
Carbonara CEM; Reis LMD; Quadros KRDS; Roza NAV; Sano R; Carvalho AB; Jorgetti V; Oliveira RB
J Bras Nefrol; 2020 Jan; 42(2):138-146. PubMed ID: 32756862
[TBL] [Abstract][Full Text] [Related]
5. Overview of renal osteodystrophy in Brazil: a cross-sectional study.
Carbonara CEM; Roza NAV; Reis LM; Carvalho AB; Jorgetti V; Oliveira RB
J Bras Nefrol; 2023; 45(2):257-261. PubMed ID: 37158484
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
Klaus G; Watson A; Edefonti A; Fischbach M; Rönnholm K; Schaefer F; Simkova E; Stefanidis CJ; Strazdins V; Vande Walle J; Schröder C; Zurowska A; Ekim M;
Pediatr Nephrol; 2006 Feb; 21(2):151-9. PubMed ID: 16247644
[TBL] [Abstract][Full Text] [Related]
7. Study on the Effect of Low Calcium Dialysate on Biochemical Profile of Adynamic Bone Disease in Patients on Maintenance Hemodialysis.
Sethi S; Dhooria HS; Goyal S; Makkar V
Saudi J Kidney Dis Transpl; 2023 May; 34(3):224-234. PubMed ID: 38231717
[TBL] [Abstract][Full Text] [Related]
8. Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Wang Y; Xie G; Huang Y; Zhang H; Yang B; Mao Z
PLoS One; 2015; 10(3):e0121376. PubMed ID: 25799184
[TBL] [Abstract][Full Text] [Related]
9. Association of incidence rate of spontaneous tendon rupture and renal bone disease in end-stage renal disease patients' cohort.
Koh KH; Arimuthu DA
Semin Dial; 2023; 36(6):462-467. PubMed ID: 37170692
[TBL] [Abstract][Full Text] [Related]
10. Low calcium dialysate combined with CaCO
Gao Z; Lun LD; Li XL
Exp Ther Med; 2013 Jun; 5(6):1732-1736. PubMed ID: 23837063
[TBL] [Abstract][Full Text] [Related]
11. Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease.
Elkhouli E; Nagy E; Santos CGS; Barreto FC; Chaer J; Jorgetti V; El-Husseini A
Osteoporos Int; 2023 Dec; 34(12):2003-2012. PubMed ID: 37658999
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients.
Ossareh S
Int J Nephrol Renovasc Dis; 2014; 7():161-8. PubMed ID: 24855385
[TBL] [Abstract][Full Text] [Related]
13. Renal osteodystrophy and clinical outcomes: a prospective cohort study.
Carbonara CEM; Barreto J; Roza NAV; Quadros KDS; Reis LMD; Carvalho AB; Sposito AC; Jorgetti V; Oliveira RB
J Bras Nefrol; 2024; 46(2):e20230119. PubMed ID: 37947359
[TBL] [Abstract][Full Text] [Related]
14. The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.
McAlister L; Pugh P; Greenbaum L; Haffner D; Rees L; Anderson C; Desloovere A; Nelms C; Oosterveld M; Paglialonga F; Polderman N; Qizalbash L; Renken-Terhaerdt J; Tuokkola J; Warady B; Walle JV; Shaw V; Shroff R
Pediatr Nephrol; 2020 Mar; 35(3):501-518. PubMed ID: 31667620
[TBL] [Abstract][Full Text] [Related]
15. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.
Zand L; Kumar R
Endocrinol Metab Clin North Am; 2017 Dec; 46(4):983-1007. PubMed ID: 29080646
[TBL] [Abstract][Full Text] [Related]
16. Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease.
Duque EJ; Elias RM; Moysés RMA
Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):326-331. PubMed ID: 35703226
[TBL] [Abstract][Full Text] [Related]
17. When primary hyperparathyroidism comes as good news.
Gallo D; Rosetti S; Marcon I; Armiraglio E; Parafioriti A; Pinotti G; Perrucchini G; Patera B; Gentile L; Tanda ML; Bartalena L; Piantanida E
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554826
[TBL] [Abstract][Full Text] [Related]
18. Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management.
Habas E; Eledrisi M; Khan F; Elzouki AY
Cureus; 2021 Jul; 13(7):e16388. PubMed ID: 34408941
[TBL] [Abstract][Full Text] [Related]
19. Mineral and bone disorder and management in the China Dialysis Outcomes and Practice Patterns Study.
Wang J; Bieber BA; Hou FF; Port FK; Anand S
Chin Med J (Engl); 2019 Dec; 132(23):2775-2782. PubMed ID: 31856047
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
